Clinical Trials Details

S1900A LungMAP - SUBSTUDY (Lung)

A Phase 11 Study of RUCAPARIB in Patients with Genomic LOH High and/or DELETERIOUS BRCA1/2 Mutation STAGE IV OR Recurrent Non-Small Cell Lung Cancers

Clinical Trial Categories

  • Cancers and Other Neoplasms